<DOC>
	<DOCNO>NCT02698644</DOCNO>
	<brief_summary>Is assess effectiveness hysteroscopic tubal application Iso Amyl-2-cyanoacrylate occlude uterine tube woman , would make easy approach occlude tube hydrosalpinx prior IVF tubal sterilization .</brief_summary>
	<brief_title>Hysteroscopic Tubal Occlusion With Use Iso Amyl-2-cyanoacrylate</brief_title>
	<detailed_description>The study conduct accord guideline human experimentation 1975 Declaration Helsinki . For patient take sign informed consent , transcervical hysteroscopic cannulation proximal one centimeter fallopian tube , do use 5 Fr , 42cm long , polyethylene ureteric catheter , 0.5 ml Iso Amyl-2-cyanoacrylate ( AMCRYLATEÂ® ) inject side . All surgical procedure perform without anesthesia , premedication NSAID ( e.g . NaproxenR ) give orally one hour procedure . Each patient close observation first 24 hour postprocedure sign inflammation abdominal pain , tenderness fever vital data . Total abdominal hysterectomy bilateral salpingoophorectomy do , second day , week , two week three week four week injection , . Hysterectomy sample sent histopathologist ass degree tubal occlusion extent severity inflammation tubal wall .</detailed_description>
	<criteria>patient plan abdominal hysterectomy well see tubal ostia hysteroscope Any patient Upper low genital tract infection evidence fever , low abdominal pain tenderness abnormal vaginal discharge exclude study</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>